332 related articles for article (PubMed ID: 19666903)
1. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Yew WW; Chang KC; Chau CH
J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
[No Abstract] [Full Text] [Related]
2. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
Koh WJ; Shim TS
J Antimicrob Chemother; 2009 Nov; 64(5):1119-20. PubMed ID: 19744986
[No Abstract] [Full Text] [Related]
3. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Sotgiu G; Lange C; Richardson MD; Matteelli A; Centis R; Eker B; Guenther G; Spanevello A; Migliori GB;
J Antimicrob Chemother; 2009 Oct; 64(4):879-83; author reply 883-4. PubMed ID: 19651787
[No Abstract] [Full Text] [Related]
4. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
[TBL] [Abstract][Full Text] [Related]
5. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
Nam HS; Koh WJ; Kwon OJ; Cho SN; Shim TS
Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
[No Abstract] [Full Text] [Related]
6. Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.
Dauby N; Muylle I; Mouchet F; Sergysels R; Payen MC
Pediatr Infect Dis J; 2011 Sep; 30(9):812-3. PubMed ID: 21378593
[TBL] [Abstract][Full Text] [Related]
7. Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
Schaaf HS; Willemse M; Donald PR
Pediatr Infect Dis J; 2009 Aug; 28(8):748-50. PubMed ID: 19633523
[TBL] [Abstract][Full Text] [Related]
8. Linezolid in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis in paediatric patients: experience of a paediatric infectious diseases unit.
Kjöllerström P; Brito MJ; Gouveia C; Ferreira G; Varandas L
Scand J Infect Dis; 2011 Jul; 43(6-7):556-9. PubMed ID: 21391771
[TBL] [Abstract][Full Text] [Related]
9. [The analysis of clinical data about the treatment of linezolid against tuberculosis].
Nie WJ; Chu NH
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):601-3. PubMed ID: 24252739
[No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
[TBL] [Abstract][Full Text] [Related]
11. Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.
Yew WW; Chau CH; Wen KH
Int J Tuberc Lung Dis; 2008 Mar; 12(3):345-6. PubMed ID: 18284844
[No Abstract] [Full Text] [Related]
12. Treatment of extensively drug-resistant tuberculosis.
Aggarwal D; Mohapatra PR; Janmeja AK
Lancet; 2009 Jan; 373(9657):26-7; author reply 27-8. PubMed ID: 19121714
[No Abstract] [Full Text] [Related]
13. Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Sotgiu G; Centis R; D'Ambrosio L; Castiglia P; Migliori GB
Eur Respir J; 2015 Jan; 45(1):287-9. PubMed ID: 25552740
[No Abstract] [Full Text] [Related]
14. Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Weiss T; Schönfeld N; Otto-Knapp R; Bös L; Bettermann G; Mauch H; Bauer TT; Rüssmann H
Eur Respir J; 2015 Jan; 45(1):285-7. PubMed ID: 25552739
[No Abstract] [Full Text] [Related]
15. Comment on: daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.
Bolhuis MS; van Altena R; Alffenaar JW
J Antimicrob Chemother; 2012 Aug; 67(8):2055-6; author reply 2056-7. PubMed ID: 22544851
[No Abstract] [Full Text] [Related]
16. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.
Koh WJ; Kang YR; Jeon K; Kwon OJ; Lyu J; Kim WS; Shim TS
J Antimicrob Chemother; 2012 Jun; 67(6):1503-7. PubMed ID: 22403262
[TBL] [Abstract][Full Text] [Related]
17. Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.
Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB;
Eur Respir J; 2013 Jul; 42(1):288-90. PubMed ID: 23813314
[No Abstract] [Full Text] [Related]
18. Treatment of multidrug-resistant and extensively drug-resistant tuberculosis in adolescent patients.
Rodrigues M; Brito M; Villar M; Correia P
Pediatr Infect Dis J; 2014 Jun; 33(6):657-9. PubMed ID: 24642519
[TBL] [Abstract][Full Text] [Related]
19. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
Anger HA; Dworkin F; Sharma S; Munsiff SS; Nilsen DM; Ahuja SD
J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
[TBL] [Abstract][Full Text] [Related]
20. Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis?
Chang KC; Yew WW; Cheung SW; Leung CC; Tam CM; Chau CH; Wen PK; Chan RC
Antimicrob Agents Chemother; 2013 Jul; 57(7):3445-9. PubMed ID: 23650165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
